Previous studies also demonstrated that high MSLN expression was correlated with poor prognosis in other cancer types, including ovarian cancer [24], biliary cancer [25, 26], pancreatic AC [27, 28], lung AC [29, 30], and triple-negative breast cancer [31, 32]. The gene discussed is MSLN; the disease is triple-negative breast carcinoma.